Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 5031926, 17 pages
https://doi.org/10.1155/2017/5031926
Research Article

Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway

1Division of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2Clinical Research Institute, Daejeon St. Mary’s Hospital, Daejeon, Republic of Korea

Correspondence should be addressed to Hyeon Seok Hwang; rk.ca.cilohtac@shgnawh

Received 4 December 2016; Accepted 23 February 2017; Published 29 March 2017

Academic Editor: Vladimir Jakovljevic

Copyright © 2017 Yu Ah Hong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yu Ah Hong, Keum Jin Yang, So Young Jung, et al., “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 5031926, 17 pages, 2017. https://doi.org/10.1155/2017/5031926.